KEY
PERSON
PERSON
Oksana Temirbekova leads YamaYami as CEO.
The Device for local transdermal drug delivery and gene therapy developed by her became one of the best inventions according to IFIA (International Federation of Inventors’Associations), the Korean Intellectual Property Office (KIPO) and the Korea Women Inventors Association (KWIA) in 2024.
Under her leadership, the transdermal technology was included in the list of the TOP-10 most promising technologies in the world according to Sephora/LVMH.
The Device for local transdermal drug delivery and gene therapy developed by her became one of the best inventions according to IFIA (International Federation of Inventors’Associations), the Korean Intellectual Property Office (KIPO) and the Korea Women Inventors Association (KWIA) in 2024.
Under her leadership, the transdermal technology was included in the list of the TOP-10 most promising technologies in the world according to Sephora/LVMH.
CEO, CO-founder YamaYami
Oksana Temirbekova
FACTS
The best innovative female manager among the BRICs
In 2021 she became the best innovative female manager among the BRICs countries according to the assessment of the international company Deloitte.
MISSION
OUR
MISSION
Our mission is to improve the quality of human life through increasing the effectiveness of drugs.
Every day we work on the efficiency of drug delivery and increasing their effectiveness.
PATCH
Transdermal Botulinum Toxin smart patches for safe and needle-free Botulinum Toxin delivery.
BOTOX
PATCH
Markets for the technology application.
01
03
04
02
PEDIATRIC HEALTH TRACK
LOCAL GENE THERAPY
TRANSDERMAL VACCINATION
PROJECT
OUR
PRODUCT
BOTULINUM TOXIN DELIVERY
CONTACT
CONTACT
